Deep search
Profile Picture
  • All
  • Search
  • Copilot
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Past 7 days
    • Any time
    • Past hour
    • Past 24 hours
    • Past 30 days

News

The Lancet3d
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
Copyright: © 2015 Elsevier Ltd. Published by Elsevier Ltd.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

Foreign student ban halted
Musk leaving Trump admin
Boat, human remains found
To challenge Graham
US revokes parole of MX girl
Oregon zoo owner arrested
Kevin Costner sued
‘Chucky' actor dies at 61
Mysterious object spotted
Sells Rhode in $1B deal
Alex Foster dies
Weekly jobless claims rise
Washington park shooting
Gray whale deaths in CA
‘The Golden Child' actor dies
16 states sue Trump admin
Tropical Storm Alvin forms
Killer heat ahead?
Trump nominates Emil Bove
HHS cancels contract
Trump commutes sentence
Announce new partnership
SK navy patrol plane crashes
Pardons reality TV stars
Judge on deportation bid
US targets Chinese students
Judge grants ICE bail
Thunder reach NBA Finals
Israel OKs more settlements
DOJ probes California
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy